These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25752337)

  • 1. Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
    Aubert L; Pichierri S; Hommet C; Camus V; Berrut G; de Decker L
    J Am Geriatr Soc; 2015 Mar; 63(3):543-7. PubMed ID: 25752337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S; van Kan GA; Soto ME; Houles M; Cantet C; Nourhashemi F; Vellas B; Pahor M; Rolland Y
    J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
    Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
    J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Comorbidities in Patients With Cognitive Complaint and Caregiver Burden: A Cross-Sectional Study.
    Dauphinot V; Ravier A; Novais T; Delphin-Combe F; Moutet C; Xie J; Mouchoux C; Krolak-Salmon P
    J Am Med Dir Assoc; 2016 Mar; 17(3):232-7. PubMed ID: 26620070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.
    Soto ME; Secher M; Gillette-Guyonnet S; Abellan van Kan G; Andrieu S; Nourhashemi F; Rolland Y; Vellas B
    J Alzheimers Dis; 2012; 28(3):647-54. PubMed ID: 22045479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.
    Wilson RS; McCann JJ; Li Y; Aggarwal NT; Gilley DW; Evans DA
    Am J Psychiatry; 2007 Jun; 164(6):910-5. PubMed ID: 17541050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
    Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease?
    Germain S; Adam S; Olivier C; Cash H; Ousset PJ; Andrieu S; Vellas B; Meulemans T; Reynish E; Salmon E;
    J Alzheimers Dis; 2009; 17(1):105-14. PubMed ID: 19494435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease.
    Dumont C; Voisin T; Nourhashemi F; Andrieu S; Koning M; Vellas B
    J Nutr Health Aging; 2005; 9(3):163-7. PubMed ID: 15864396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study.
    Lechowski L; Benoit M; Chassagne P; Vedel I; Tortrat D; Teillet L; Vellas B
    Int J Geriatr Psychiatry; 2009 Apr; 24(4):341-6. PubMed ID: 18814198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.